Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments

case-control study: A history of exposure to antipsychotics, particularly high-metabolic-risk APs, is associated with current AP-induced metabolic disturbances. A history of high-metabolic-risk APs was associated with a higher risk of LDL-C ≥3.37 mmol/L–1